IPO registrations (S-1, F-1) · Registrants
VIROPHARMA INC
- SEC CIK
- 946840 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 1996-09-20, last 1997-07-22; 2 initial registrations, 8 amendments
- Outcome
- Final prospectus filed 1996-11-20
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 730 STOCKTON DRIVE, Exton, PA 19341
- EIN
- 23-2789550
- EDGAR entity type
- operating
- Insiders and CEO pay
- VIROPHARMA INC on the corporate pages
Offering terms
- Final price
- $7.00 per share (424B4 filed 1996-11-20, an initial public offering)
- Shares sold
- 2,250,000
- Gross proceeds
- $15,750,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol VPHM
- Lead underwriters
- Cowen (721,000 shares)
- Syndicate
- J.P. Morgan (479,000); Bear Stearns (60,000); Alex. Brown & Sons (60,000); Dillon, Read & Co. Inc (60,000); Donaldson, Lufkin & Jenrette (60,000); Hambrecht & Quist (60,000); Oppenheimer (60,000); PaineWebber (60,000); Robertson Stephens (60,000); Citigroup (60,000); UBS (60,000); Wasserstein Perella Securities, Inc (60,000); J.C. Bradford & Co (30,000); Gerard Klauer Mattison & Co., LLC (30,000); Gruntal & Co., Incorporated (30,000); Interstate/Johnson Lane Corporation (30,000); Janney Montgomery Scott (30,000); Kaufman Bros., L.P (30,000); KeyBanc Capital Markets (30,000); Pacific Growth Equities, Inc (30,000); Parker/Hunter Incorporated (30,000); Pennsylvania Merchant Group Ltd (30,000); Ragen Mackenzie Incorporated (30,000); Raymond James (30,000); Vector Securities International, Inc (30,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form 5500 plan sponsor: SHIRE VIROPHARMA, INC. EXACT (EIN (EXACT))
- Federal award recipient: VIROPHARMA INCORPORATED Fuzzy (name and state)
- Lobbying client: VIROPHARMA Fuzzy (name and state)
- Lobbying client: VIROPHARMA INCORPORATED Fuzzy (name and state)
- Lobbying client: VIROPHARMA INCORPORATED Fuzzy (name and state)
- Lobbying client: VIROPHARMA INCORPORATED Fuzzy (name and state)
- Lobbying client: VIROPHARMA INCORPORATED Fuzzy (name and state)
- Lobbying client: VIROPHARMA INCORPORATED Fuzzy (name and state)
- Lobbying registrant: VIROPHARMA INCORPORATED Fuzzy (name and state)
- SEC filer: VIROPHARMA INC EXACT (CIK (EXACT))
- Person page: Paul A Brooke Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 12
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 1996-09-20 | S-1 | S-1 (registration) | VIROPHARMA INC | 0000950109-96-006092 ↗ |
| 1996-09-25 | S-1/A | S-1/A (amendment) | VIROPHARMA INC | 0000950109-96-006212 ↗ |
| 1996-10-25 | S-1/A | S-1/A (amendment) | VIROPHARMA INC | 0000950109-96-006908 ↗ |
| 1996-11-08 | S-1/A | S-1/A (amendment) | VIROPHARMA INC | 0000950109-96-007255 ↗ |
| 1996-11-14 | S-1/A | S-1/A (amendment) | VIROPHARMA INC | 0000950109-96-007625 ↗ |
| 1996-11-19 | S-1/A | S-1/A (amendment) | VIROPHARMA INC | 0000950109-96-007729 ↗ |
| 1996-11-20 | 424B4 | 424B4 (final prospectus) | VIROPHARMA INC | 0000950109-96-007792 ↗ |
| 1997-06-25 | S-1 | S-1 (registration) | VIROPHARMA INC | 0001036050-97-000400 ↗ |
| 1997-07-03 | S-1/A | S-1/A (amendment) | VIROPHARMA INC | 0001036050-97-000455 ↗ |
| 1997-07-11 | S-1/A | S-1/A (amendment) | VIROPHARMA INC | 0001036050-97-000478 ↗ |
| 1997-07-22 | S-1/A | S-1/A (amendment) | VIROPHARMA INC | 0001036050-97-000505 ↗ |
| 1997-07-23 | 424B4 | 424B4 (final prospectus) | VIROPHARMA INC | 0001036050-97-000509 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 1996-11-19 | S-1/A | registration statement | $7.00 | 2,250,000 | $15,750,000 | Nasdaq VPHM | 2 | from the submission text; price sentence, shares headline, proceeds computed, cover names 2 | document ↗ | |
| 1996-11-20 | 424B4 | final prospectus | $7.00 | 2,250,000 | $15,750,000 | Nasdaq VPHM | 26 | from the submission text; price sentence, shares headline, proceeds computed, underwriting table 26, cover names 2 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Broom Colin MD | Officer | VP & Chief Scientific Officer | 30 | 2006–2014 | |
| DE ROSEN MICHEL | Director; Director,Officer | Chief Executive Officer | 11 | 2006–2008 | |
| DOYLE THOMAS F | Officer | VP, General Counsel; VP Strategic Initiatives | 24 | 2006–2014 | |
| MILANO VINCENT | Director,Officer; Officer | President and CEO; President, CEO & CFO; VP, COO & CFO | 28 | 2006–2014 | |
| Tarnoff Joshua M | Officer | VP, Chief Commerical Officer | 2 | 2006 | |
| Leone John R | Director | 12 | 2006–2014 | ||
| BALDINO FRANK JR | Director | 4 | 2006–2010 | ||
| BROOKE PAUL A | Director | 13 | 2006–2014 | person page Fuzzy | |
| CLAYPOOL WILLIAM D MD | Director | 19 | 2006–2014 | ||
| DOUGHERTY MICHAEL R | Director | 12 | 2006–2014 | ||
| GLASER ROBERT | Director | 17 | 2006–2014 | ||
| 14159 capital (GP), LLC | TenPercentOwner | 22 | 2006–2011 | ||
| Baker Biotech Capital (GP), LLC | TenPercentOwner | 17 | 2006–2011 | ||
| Baker Biotech Capital II (GP), LLC | TenPercentOwner | 1 | 2006 | ||
| Baker Biotech Capital III (GP), LLC | TenPercentOwner | 21 | 2006–2011 | ||
| Baker Biotech Capital III (Z) (GP), LLC | TenPercentOwner | 1 | 2006 | ||
| Baker Biotech Capital II (Z) (GP), LLC | TenPercentOwner | 1 | 2006 | ||
| Baker Bros. Capital (GP), LLC | TenPercentOwner | 15 | 2006–2011 | ||
| BAKER FELIX | TenPercentOwner | 90 | 2006–2011 | ||
| BAKER JULIAN | TenPercentOwner | 90 | 2006–2011 | ||
| Baker / Tisch Capital (GP), LLC | TenPercentOwner | 12 | 2006–2011 | ||
| PIEN HOWARD H | Director | 10 | 2006–2014 | ||
| SOLAND DANIEL B | Officer | VP, Chief Commercial Officer; VP, Chief Operating Officer | 27 | 2006–2014 | |
| Pietrusko Robert | Officer | VP, Regulatory & Quality | 25 | 2007–2014 | |
| Wolf John Peter III | Officer | VP, General Counsel | 19 | 2008–2014 | |
| Morris Richard Steven | Officer | Chief Accounting Officer | 15 | 2008–2012 | |
| Rowland Charles A Jr | Officer | Chief Financial Officer; VP, Chief Financial Officer | 21 | 2008–2014 | |
| Fletcher Robert C. | Officer | V.P., Business Development | 12 | 2011–2014 | |
| McHugh Julie | Director | 7 | 2012–2014 | ||
| Kirby John J. | Officer | V.P., Chief Accounting Officer | 5 | 2012–2014 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Federal award recipient | VIROPHARMA INCORPORATED | PA | Federal spending (USAspending) | name and state |
| Lobbying client | VIROPHARMA | PA | Federal lobbying (LDA) | name and state |
| Lobbying client | VIROPHARMA INCORPORATED | PA | Federal lobbying (LDA) | name and state |
| Lobbying client | VIROPHARMA INCORPORATED | PA | Federal lobbying (LDA) | name and state |
| Lobbying client | VIROPHARMA INCORPORATED | PA | Federal lobbying (LDA) | name and state |
| Lobbying client | VIROPHARMA INCORPORATED | PA | Federal lobbying (LDA) | name and state |
| Lobbying client | VIROPHARMA INCORPORATED | PA | Federal lobbying (LDA) | name and state |
| Lobbying registrant | VIROPHARMA INCORPORATED | PA | Federal lobbying (LDA) | name and state |
| Patent assignee | ViroPharma Incorporated | PA | Patents (USPTO) | name and state |
| SEC filer | VIROPHARMA INC | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | ViroPharma Incorporated | PA | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | SHIRE VIROPHARMA, INC. | EIN (EXACT) | ||
| Person page | Paul A Brooke | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, PA first:
- COLLAGENEX PHARMACEUTICALS INC PA
- ORAPHARMA INC PA
- VICURON PHARMACEUTICALS INC PA
- INOVIO PHARMACEUTICALS, INC. PA
- ADOLOR CORP PA
- PROTARGA INC PA
- Traws Pharma, Inc. PA
- MADRIGAL PHARMACEUTICALS, INC. PA
- Vitae Pharmaceuticals, Inc PA
- PhaseBio Pharmaceuticals Inc PA
In other datasets, the same topic (Health) in PA:
- Nonprofit: 445 FOUNDATION (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health